Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

the better health company (australia) pty - ascorbic acid, quantity: 50 mg; sambucus nigra, quantity: 32 mg (equivalent: sambucus nigra, qty 224 mg); allium sativum, quantity: 50 mg (equivalent: allium sativum, qty 600 mg); olea europaea, quantity: 500 mg (equivalent: olea europaea, qty 5 g; equivalent: oleuropein, qty 100 mg); zinc citrate, quantity: 14.5 mg (equivalent: zinc, qty 4.95 mg); handroanthus impetiginosus, quantity: 50 mg (equivalent: handroanthus impetiginosus, qty 200 mg); echinacea purpurea, quantity: 22.22 mg (equivalent: echinacea p - capsule, hard - excipient ingredients: magnesium stearate; maltodextrin; colloidal anhydrous silica; titanium dioxide; hypromellose; purified water; pectin; carrageenan - antioxidant/reduce free radicals formed in the body ; maintain/support general health and wellbeing ; traditionally used in western herbal medicine to antipyretic/febrifuge/relieve mild fever/reduce body temperature/body cooling ; maintain/support immune system health ; maintain/support healthy immune system function ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; traditionally used in western herbal medicine to expectorant/clear respiratory tract mucous ; maintain/support skin regeneration ; maintain/support wound healing

Malaysia - Inggeris - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

bioalpha international sdn. bhd. - monascus purpureus; allium sativum; olea europaea -

Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

curium netherlands b.v. - gallium (67 ga) citrate - solution for injection - 37 megabecquerel(s)/millilitre - other diagnostic radiopharmaceuticals for inflammation and infection detection; gallium (67ga) citrate

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

standard homeopathic company - allium cepa whole (unii: 8p2vlg2456) (allium cepa whole - unii:8p2vlg2456) - allium cepa whole 30 [hp_x] in 1 g - runny nose,cold or hay fever

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

endeavour ch pty ltd - ascorbic acid,allium sativum,echinacea purpurea,olea europaea,zinc citrate dihydrate -

Malaysia - Inggeris - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

nmy manufacturing sdn bhd - cinnamomum burmanni; allium sativum; curcuma longa; zingiber officinale; olea europaea -

Malaysia - Inggeris - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

nmy manufacturing sdn bhd - cinnamomum burmanni; zingiber officinale; olea europaea; allium sativum; curcuma longa -

Malaysia - Inggeris - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

vihsdia enterprise - gymnema sylvestre; olea europaea; allium sativum; camellia sinensis; spirulina platensis -

Malaysia - Inggeris - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

bionion sdn bhd - cod liver oil; evening primrose oil (oenothera biennis); sheep placenta; krill oil; olive fruit extract (olea europaea); garlic oil (allium sativum) -

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

ucsf radiopharmaceutical facility - gallium ga-68 gozetotide (unii: zj0ekr6m10) (gallium ga-68 gozetotide - unii:zj0ekr6m10) - gallium ga 68 gozeotide injection is indicated for positron emission tomography (pet) of prostate-specific membrane antigen (psma) positive lesions in men with prostate cancer: - with suspected metastasis who are candidates for initial definitive therapy. - with suspected recurrence based on elevated serum prostate-specific antigen (psa) level. none risk summary gallium ga 68 gozetotide injection is not indicated for use in females. there are no available data with gallium ga 68 gozetotide injection use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. all radiopharmaceuticals, including gallium ga 68 gozetotide injection, have the potential to cause fetal harm depending on the fetal stage of development and the magnitude of the radiation dose. animal reproduction studies have not been conducted with gallium ga 68 gozetotide injection. risk summary gallium ga 68 gozetotide injection is not indicated for use in females. there ar